Languita, Cybren .

HRN: 19-66-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CEFUROXIME 750MG (VIAL)
10/29/2023
11/04/2023
IV
335mg
Q8h
Urinary Tract Infection
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes